Project archive

Cancel
  • The aim of the MyCellFight project is to develop a fully automated immune chip able to predict the specific immune responses of individuals.

    more info
  • The aim of the toxicokinetic study conducted at Fraunhofer ITEM was to determine whether and to what extent carbon black can be absorbed in the body or systemically distributed.

    more info
  • The foodstuffs will be screened for unknown halogenated organic chemicals by using a non-targeted screening strategy. Experts from Fraunhofer ITEM are working to establish targeted detection limits based on the toxicity of the substances.

    more info
  • Respiratory syncytial virus (RSV) usually causes mild airway infections in healthy adults. Fraunhofer ITEM scientists have established a model that mimics the viral infection ex vivo in viable human lung tissue (precision-cut lung slices – PCLS for short).

    more info
  • The aim of the project PhagoFlow in Braunschweig is to determine the infrastructural requirements for magistral production of phages in Germany to enable treatment of patients with wound infections of the extremities.

    more info
  • During many years of research on malignant diseases, scientists at Fraunhofer ITEM in Regensburg have gained special expertise in analyzing single cells from liquid biopsies. With some minor adjustments, they can apply – and have already applied – the established, partly automated technologies for single-cell DNA and RNA analysis from clinical samples to other cell types in order to characterize these in more detail and to make use of the information thus obtained, for example to identify biomarkers.

    more info
  • Starting in January 2019, 13 partners from 7 European countries, including research institutes, universities and small and medium-sized enterprises, have been collaborating in the Horizon 2020 project MDOT (Medical Device Obligations Taskforce). This project is being coordinated by Fraunhofer ITEM, with a grant size of 8.3 million euros and 5 years overall duration.

    more info